Skip to content

Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania

MWOTAJI: Making Women's Options for HIV Prevention In Tanzania Accessible, and Joining in Implementation Science Capacity Building

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07687888
Acronym
MWOTAJI
Enrollment
2818
Registered
2026-07-07
Start date
2026-09-01
Completion date
2028-02-01
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, PrEP

Keywords

PrEP, young women, pharmacies

Brief summary

Implementation study comparing standard pre-exposure prophylaxis (PrEP) services to four models of pharmacy-based PrEP access for young women aged 18-24 (YW) in Tanzania. At 9 months, all sites converge to one pharmacy-based PrEP model and are randomly allocated to one of two cost sharing models to increase the program's potential for sustainability.

Detailed description

This study will evaluate the effectiveness of pharmacy-based PrEP implementation for YW in the Lake Zone, Tanzania. Four models for pharmacy-based PrEP delivery will be evaluated and compared to pharmacies that do not provide any PrEP services for 9 months (phase I of the implementation study). The PrEP implementation models build on one another with each pharmacy-based PrEP model providing progressively expanded access to PrEP in pharmacies for YW. All PrEP implementation models will be implemented alongside a girl-friendly loyalty program (Mwotaji Program) offering free sexual and reproductive health products including HIV self-test kits, pregnancy tests, and contraceptives. Comparison: Standard facility based PrEP services to YW. After 9 months (phase II), all pharmacies will implement the best performing PrEP model, based on findings from phase I. Moreover, all 50 pharmacies will implement cost-sharing. The investigators will assess acceptability, feasibility, and potential for sustainability of the pharmacy-based PrEP models. Two cost-sharing approaches will be randomized across the CRPS in a 3:2 ratio: 1. Fee-for-service model: PrEP refills provided for 500 Tanzanian Shillings (TZS) each, a standard cash-based transaction for user fees, benchmarked with data from prior studies. 2. Loyalty hybrid model: PrEP refills provided for free with any shop purchase or a fee of 500 TZS without a purchase. The implementation study comprises a cohort study (parent study) conducted among YW and three sub-studies: * Household survey (cross-sectional survey conducted with YW) * Pharmacy surveys (surveys conducted with pharmacy staff) * Stakeholder surveys (surveys conducted with health facility staff and governmental stakeholders)

Interventions

BEHAVIORALPharmacy-based PrEP services

Provision of PrEP services to AGYW in pharmacies.

BEHAVIORALDistribution of HIV self-test kits

Provision of free HIV self-test kits to AGYW in pharmacies.

Sponsors

Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of California, Berkeley
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

(Parent study: YW cohort study): 1. Female sex; 2. Age 18-24 at the baseline visit; 3. Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania with no known plans to move; 4. Interested in starting PrEP; 5. Access to a mobile phone (either own phone or borrowed phone); and 6. Eligible for PrEP based on Tanzania National PrEP Guidelines behavioral screening criteria

Exclusion criteria

Currently taking PrEP (refilled a PrEP prescription within the past 28 days at enrollment). Inclusion Criteria (Sub-study: YW household survey): 1. Female sex; 2. Age 18-24; and 3. Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania.

Design outcomes

Primary

MeasureTime frameDescription
Effective use of PrEP9 monthsYW received a PrEP refill for all months during which an YW reports being at risk for HIV and PrEP eligible over the 9-month study period (among PrEP initiates only)
Persistent use of PrEP9 monthsYW picked up all scheduled PrEP refills without a delay of \>28 days over the 9- month study period (among PrEP initiates only)
Reach of PrEP implementation model9 monthsHeard of pharmacy-based PrEP services (including screening, referrals, refills, or initiation)

Secondary

MeasureTime frameDescription
Acceptability of PrEP implementation model9 months, 15 monthsYW agrees that PrEP implementation model is acceptable (e.g., satisfactory, high-quality, youth-friendly, discreet, affordable); Pharmacy staff agree that PrEP implementation model is acceptable and/or consistent with AGYW needs
Fidelity to PrEP implementation model9 months, 15 monthsPharmacy provision of PrEP services (screen, provide referral, refill, or initiate AGYW on PrEP) at least once per month
Feasibility of PrEP implementation model9 months, 15 monthsAgrees that PrEP implementation model at pharmacies is more accessible than seeking PrEP services at health facilities; Agrees that there is sufficient capacity (e.g., space, time, privacy, will) to deliver a particular PrEP implementation model
Adoption of PrEP implementation model9 months, 15 monthsPharmacy is implementing the PrEP model as assigned.

Countries

Tanzania

Contacts

CONTACTMackfallen G Anasel, PhD
mganasel@mzumbe.ac.tz+255784705072
CONTACTLila A Sheira, PhD MPH
Lila.sheira@ucsf.edu
PRINCIPAL_INVESTIGATORMackfallen I Anasel, PhD

Mzumbe University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026